Literature DB >> 26068998

Characterization of Whole Body Cholesterol Fluxes in the Mouse.

Gemma Brufau1, Albert K Groen1,2.   

Abstract

Atherosclerosis is characterized by excessive cholesterol accumulation in the vessel wall. Current therapies mainly aim at decreasing influx through lowering plasma LDL-cholesterol levels. The challenge is to develop therapeutic interventions to increase efflux of excess cholesterol from the vessel wall. The pathway that mediates this efflux from vessel wall to final excretion in the feces is called reverse cholesterol transport. Recently, it has become apparent that the intestine plays an important regulatory role in this pathway. This article describes in detail a variety of experimental approaches to measure cholesterol fluxes in the hepatobiliary system as well as in the intestinal pathway. Curr. Protoc. Mouse Biol. 1:413-427 © 2011 by John Wiley & Sons, Inc.
Copyright © 2011 John Wiley & Sons, Inc.

Entities:  

Keywords:  biliary excretion; excretion; fecal cholesterol excretion; mouse; transintestinal cholesterol

Year:  2011        PMID: 26068998     DOI: 10.1002/9780470942390.mo110118

Source DB:  PubMed          Journal:  Curr Protoc Mouse Biol        ISSN: 2161-2617


  3 in total

1.  Statins increase hepatic cholesterol synthesis and stimulate fecal cholesterol elimination in mice.

Authors:  Marleen Schonewille; Jan Freark de Boer; Laura Mele; Henk Wolters; Vincent W Bloks; Justina C Wolters; Jan A Kuivenhoven; Uwe J F Tietge; Gemma Brufau; Albert K Groen
Journal:  J Lipid Res       Date:  2016-06-16       Impact factor: 5.922

2.  A protocol for evaluation of Rett Syndrome symptom improvement by metabolic modulators in Mecp2-mutant mice.

Authors:  Christie M Buchovecky; Misty G Hill; Jennifer M Borkey; Stephanie M Kyle; Monica J Justice
Journal:  Curr Protoc Mouse Biol       Date:  2013

3.  A human-like bile acid pool induced by deletion of hepatic Cyp2c70 modulates effects of FXR activation in mice.

Authors:  Jan Freark de Boer; Esther Verkade; Niels L Mulder; Hilde D de Vries; Nicolette Huijkman; Martijn Koehorst; Theo Boer; Justina C Wolters; Vincent W Bloks; Bart van de Sluis; Folkert Kuipers
Journal:  J Lipid Res       Date:  2019-09-10       Impact factor: 5.922

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.